Infusion Therapy Resource Library

This white paper discusses a BD in vitro study that assessed the diffuser efficiency of iodinated contrast media during power injection with the BD Nexiva^™ Diffusics^™ closed IV catheter system.

This white paper discusses a BD study that compared the high-pressure flow rates of the BD Insyte^™ Autoguard^™ BC shielded IV catheter with blood control technology and BD Insyte^™ Autoguard^™ shielded IV catheter to determine they are similar despite blood control technology.

This white paper discusses a BD study that evaluated BD Insyte^™ Autoguard^™ BC shielded IV catheter with blood control technology gravity-based flow rate and infusion time.

This white paper discusses a BD study that evaluated the hemolysis performance of the BD Insyte^™ Autoguard^™ BC shielded IV catheter with blood control technology during blood collection.

This white paper discusses the importance of maintaining positive pressure in the IV line to maintain patency and reduce the occurrence of occlusions during infusion therapy.

This white paper discusses clamping and how positive displacement connectors, like our MaxPlus^™ clear needleless connector and MaxGuard^™ antimicrobial needleless connector, promote patient safety without requiring clamping for product function.

This white paper discusses a BD in vitro study that used fluoroscopy to investigate the role of catheter geometry in catheter performance during power injection of iodinated contrast media.

This white paper verifies flow rate performance on commonly used peripheral catheters to determine changes in flow with standard bore and minibore extension sets.

This white paper discusses an analysis of the rate of hemolysis after blood withdrawal through the MaxPlus^™ needlless connector.

This white paper discusses an analysis of the rate of hemolysis of the MaxPlus^™ needlless connector.

This white paper determines the flow rate of needleless connectors and their effect on catheter flow rate.

This white paper ascertains if the MaxPlus^™ connector can be completely flushed after aspiration or infusion with a blood product.

This white paper shows the MaxPlus^™ needleless connector maintaining its structural integrity when exposed to high-risk infusates.

This white paper discusses a BD in vitro study that measured and quantified the recoil forces impacting IV catheters.

This white paper discusses a BD study that compared the microbial ingress performance of the BD Insyte^™ Autoguard^™ BC shielded IV catheter with blood control technology vs two competitor products.

This white paper discusses IV set replacement during IV administration and how our MaxPlus^™ pressure-rated IV extension sets help keep vascular access devices from rupturing and leaking during procedures requiring pressure.

This white paper discusses a series of compatibility tests on SmartSite^™ needle-free valve component materials.

This white paper demonstrates flush procedures using our SmartSite^™ needle-free valve in an independent study.

This white paper evaluates the hemolytic potential of the SmartSite^™ needle-free valve vs. an open male luer and 18 G catheter when infusing blood products.

This white paper demonstrates our SmartSite^™ needle-free valve resisting bacterial contamination through the valve after repeated inoculations with Staphylococcus aureus.

This scientific poster describes how the University of Florida Health implemented a hospital-wide vascular access project designed to improve outcomes associated with peripheral IV therapy.